Cargando…

Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs

Detalles Bibliográficos
Autores principales: Brown, Christine E, Starr, Renate, Naranjo, Araceli, Aguilar, Brenda, Chang, Wen-Chung, Ostberg, Julie, Warden, Charles, Yuan, Yate-Ching, D'Apuzzo, Massimo, Barish, Michael E, Badie, Behnam, Jensen, Michael C, Forman, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990334/
http://dx.doi.org/10.1186/2051-1426-1-S1-P2
_version_ 1782312262323666944
author Brown, Christine E
Starr, Renate
Naranjo, Araceli
Aguilar, Brenda
Chang, Wen-Chung
Ostberg, Julie
Warden, Charles
Yuan, Yate-Ching
D'Apuzzo, Massimo
Barish, Michael E
Badie, Behnam
Jensen, Michael C
Forman, Stephen J
author_facet Brown, Christine E
Starr, Renate
Naranjo, Araceli
Aguilar, Brenda
Chang, Wen-Chung
Ostberg, Julie
Warden, Charles
Yuan, Yate-Ching
D'Apuzzo, Massimo
Barish, Michael E
Badie, Behnam
Jensen, Michael C
Forman, Stephen J
author_sort Brown, Christine E
collection PubMed
description
format Online
Article
Text
id pubmed-3990334
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39903342014-05-01 Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs Brown, Christine E Starr, Renate Naranjo, Araceli Aguilar, Brenda Chang, Wen-Chung Ostberg, Julie Warden, Charles Yuan, Yate-Ching D'Apuzzo, Massimo Barish, Michael E Badie, Behnam Jensen, Michael C Forman, Stephen J J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990334/ http://dx.doi.org/10.1186/2051-1426-1-S1-P2 Text en Copyright © 2013 Brown et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Brown, Christine E
Starr, Renate
Naranjo, Araceli
Aguilar, Brenda
Chang, Wen-Chung
Ostberg, Julie
Warden, Charles
Yuan, Yate-Ching
D'Apuzzo, Massimo
Barish, Michael E
Badie, Behnam
Jensen, Michael C
Forman, Stephen J
Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
title Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
title_full Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
title_fullStr Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
title_full_unstemmed Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
title_short Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARs
title_sort adoptive transfer of il13rα2-specific t cells for the treatment of glioblastoma: building on clinical achievements with second-generation cars
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990334/
http://dx.doi.org/10.1186/2051-1426-1-S1-P2
work_keys_str_mv AT brownchristinee adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT starrrenate adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT naranjoaraceli adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT aguilarbrenda adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT changwenchung adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT ostbergjulie adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT wardencharles adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT yuanyateching adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT dapuzzomassimo adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT barishmichaele adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT badiebehnam adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT jensenmichaelc adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars
AT formanstephenj adoptivetransferofil13ra2specifictcellsforthetreatmentofglioblastomabuildingonclinicalachievementswithsecondgenerationcars